首页 | 本学科首页   官方微博 | 高级检索  
检索        

ERKs及细胞内游离钙在内皮素-1诱导心肌细胞肥大反应中的作用
引用本文:鲁伟,刘培庆,徐江,王庭槐,龚素珍,潘敬运.ERKs及细胞内游离钙在内皮素-1诱导心肌细胞肥大反应中的作用[J].中国病理生理杂志,2001,17(6):496-500.
作者姓名:鲁伟  刘培庆  徐江  王庭槐  龚素珍  潘敬运
作者单位:1. 中山医科大学生理教研室,广东广州510089;
2. 湖北医科大学生理教研室,湖北武汉430071
基金项目:国家自然科学基金资助项目(No.39870888)
摘    要:目的:研究细胞外信号调节激酶(ERKs)及细胞内游离钙(i)在内皮素-1(ET-1)介导心肌细胞肥大反应中的作用及机制。方法:利用培养的新生大鼠心肌细胞,①以蛋白合成速率、蛋白含量及细胞表面积为心肌肥大反应的指标;②用滤纸法测定ERKs活性;③用Fura-2/AM作为钙荧光指示剂测定心肌Ca2+]i浓度。结果:①ET-1浓度依赖性增加新生大鼠心肌细胞蛋白质含量和心肌细胞表面积、ERKs活性及Ca2+]i浓度,以上作用可被ETA受体拮抗剂BQ123所完全抑制,被百日咳毒素(PTX)部分抑制,而ETB受体拮抗剂BQ788则无效;②ERKs激酶特异性抑制剂PD98059可完全抑制ET-1激活ERKs的作用,钙通道拮抗剂硝苯地平可明显抑制ET-1介导的Ca2+]i浓度增加,但二者皆仅部分抑制ET-1介导的心肌细胞肥大反应;③蛋白激酶C(PKC)选择性抑制剂staurosporine并不能明显抑制ET-1介导的ERKs激活,但可抑制ET-1介导的的Ca2+]i浓度增加及心肌细胞肥大反应。结论:ET-1主要通过ETA受体并经PTX敏感的G-蛋白介导心肌细胞肥大反应,该作用至少涉及两条途径:①通过PKC介导的心肌Ca2+]i浓度增加;②不通过PKC介导的ERKs激活。

关 键 词:内皮缩血管肽类    心肌病  肥大性  G-蛋白质类  蛋白激酶C  
文章编号:1000-4718(2001)06-0496-05
收稿时间:2000-09-12
修稿时间:2000年9月12日

Roles of ERKs and intracellular free calcium in cardiomyocyte hypertrophic response induced by endothelin-1
LU Wei,LIU Pei-qing,XU Jiang,WANG Ting-huai,GONG Su-zhen,PAN Jing-Yun.Roles of ERKs and intracellular free calcium in cardiomyocyte hypertrophic response induced by endothelin-1[J].Chinese Journal of Pathophysiology,2001,17(6):496-500.
Authors:LU Wei  LIU Pei-qing  XU Jiang  WANG Ting-huai  GONG Su-zhen  PAN Jing-Yun
Institution:1. Department of Physiology, Sun Yat-sen University of Medical Sciences, Guangzhou 510089,China;
2. epartment of Physiology, Hubei Medical University, Wuhan 430071, China
Abstract:AIM: To study the roles and mechanisms of ERKs and intracellular free calcium in cardiomyocyte hypertrophic response induced by endothelin-1(ET-1). METHODS: (1) Neonatal rat cardiomyocyte hypertrophic response was assayed by measuring cell surface area and protein content; (2) ERKs activity was determined by Whatman Paper Filter method; (3) Intracellular free calcium concentration (Ca 2 ]i) was measured using Fura-2/AM as a fluorescent indicator. RESULTS: (1) ET-1 could increase total protein production, surface area, ERKs activity and Ca 2 ]i in cultured cardiomyocyte in dose-dependent manner at concentrations ranging from 10 -9 to 10 -7 mol/L. And this effect could be abolished by BQ123, an antagonist of ET A receptor, partly inhibited by PTX, but not by BQ788, an antagonist of ET B receptor.(2)The activation of ERKs and the increase of Ca 2 ]i induced by ET-1 were obviously inhibited by PD98059, a selective ERKs kinase inhibitor, and nifedipine, a calcium channel blocker, respectively. Both antagonists partially inhibited ET-1-stimulated cardiomyocyte hypertrophic response. (3) Staurosporine, a selective PKC inhibitor, could inhibit ET-1-stimulated cardiomyocyte hypertrophic response and increase of Ca 2 ]i, but not affect the activation of ERKs. CONCLUSION: Cardiomyocyte hypertrophic response induced by ET-1 is mediated by ET A receptor coupled to PTX-sensitive G-protein, which involves at least two signalling pathways: PKC-mediated increase of Ca 2 ]i , and PKC-independent activation of ERKs.
Keywords:Endothelium  Calcium  Cardiomyopathy  hypertrophic  G-proteins  Protein kinase C
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号